Degenerative diseases represent some of the most common and impactful disorders globally, affecting hundreds of millions of people. Among them, demyelinating diseases, most notably Multiple Sclerosis ...

Neuromyelitis optica spectrum disorder (NMOSD) and related demyelinating diseases, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), represent a spectrum of autoimmune ...

If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...

A "milestone" discovery that an antibody is associated with a wider range of life-threatening autoimmune diseases than previously thought offers new hope for improved diagnosis and treatment in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Vyvgart Hytrulo in a once-weekly, 30- to 90-second subcutaneous injection to treat adults ...

Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct diagnosis.

Approximately 22,000 people in the U.S. live with a rare demyelinating condition known as neuromyelitis optica spectrum disorder (NMOSD), according to an estimate based on a cross-sectional study that ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...

In patients with NMOSD, there is a decline in executive function in terms of sustained attention, phonological verbal fluency, and working memory. Neuropsychological assessments in the clinical ...

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells - one of the few brain cell types that continue to be produced in the adult ...